Liposome drug products
Executive Summary
FDA's Pharmaceutical Science Advisory Committee will discuss pharmaceutical equivalence, bioavailability and bioequivalence of liposome drug products on July 20. The committee will also receive updates on FDA research in dermatopharmacokinetics, and comment on methods to determine drug transfer into breastmilk
You may also be interested in...
Dermatopharmacokinetics
Pharmaceutical Science Advisory Committee will not discuss dermatopharmacokinetics at June 20 meeting as previously scheduled. Remaining agenda items are unchanged (1"The Pink Sheet" June 4, In Brief)
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011